“…In rs6059655, ASIP was shown to have significantly decreased levels of expression with the risk phenotype. ASIP functions as an antagonist to MC1R through α-melanocyte-stimulating hormone to modulate melanin pigmentation ( Robbins et al., 1993 ; Yan et al., 2022 ), though an inverse expression quantitative trait loci association with MC1R was found to be nonsignificant. On the basis of 2008 case-control study, a haplotype near ASIP was found to confer an increased risk of cutaneous melanoma (OR = 1.27, 95% CI = 1.02–1.57) without adjustment for pigmentation characteristics, whereas MC1R did not ( Gudbjartsson et al., 2008 ).…”